49 mins ago · United States
Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In
What's happening
SignalsMonitor is following this as a security story. ProPublica is the outlet attached so far. The reports are tied to United States. The first report grouped here was at 29 Oct 2026, 09:30 UTC. The headline in use is “Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Last November, the Department of Health and Human Services announced the elimination of “black box” warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a key treatment for menopause symptoms. Among the officials at a press conference about the decision was Alicia Jackson, director of…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by ProPublica
Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In
Reported by 1 outlet
- ProPublica